Non-Invasive Liver Fibrosis Test Using Shear Wave Elastography

Abstract

Noninvasive liver fibrosis assessment is vital for chronic liver disease management. Although liver biopsy remains the gold standard, it is invasive with limited feasibility. Shear wave elastography (SWE) accurately evaluates liver stiffness, detecting liver fibrosis and cirrhosis across etiologies including viral hepatitis and metabolic dysfunction-associated steatotic liver disease. Despite confounders like obesity or elevated liver enzymes, SWE also aids in predicting portal hypertension and hepatocellular carcinoma risk, serving as a key tool in clinical decision-making.